Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

The profile contains critical company information including:

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Highlights

Terumo Corporation (Terumo) is a medical technology company. It undertakes the manufacturing and selling of a wide range of innovative medical care products which include hospital and medical products, equipment and pharmaceuticals. Its major products include vascular interventional products, cardiovascular surgical systems, artificial vascular grafts, blood transfusion systems, infusions systems, nutritious food, diabetes monitoring and treatment devices, cancer pain management systems, home oxygen therapy systems and consumer healthcare products.

Terumo Corporation Key Recent Developments

May 15, 2014 TERUMO Launches Expanded GLIDEWAY Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures
Mar 27, 2014 Terumo Announces Election of New Board Members
May 09, 2013 Terumo Reports Revenue Of JPY402.3 Billion In Fiscal 2013
Apr 05, 2013 Terumo Establishes Subsidiary In Russia

Key benefits of buying this profile include:

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

Note: Some sections may be missing if data is unavailable for the company

Table Of Contents

Terumo Corporation (4543) - Financial and Strategic SWOT Analysis Review
Table of Contents



Section 1 - About the Company 6
Terumo Corporation - Key Facts 6
Terumo Corporation - Key Employees 7
Terumo Corporation - Key Employee Biographies 10
Terumo Corporation - Key Operational Employees 11
Terumo Corporation - Major Products and Services 12
Terumo Corporation - Medical Equipment Pipeline Products Data 14
Terumo Corporation Pipeline Products by Equipment Type 14
Terumo Corporation Pipeline Products by Development Stage 16
Terumo Corporation - History 18
Terumo Corporation - Company Statement 24
Terumo Corporation - Locations And Subsidiaries 25
Head Office 25
Other Locations and Subsidiaries 25
Section 2 - Company Analysis 28
Terumo Corporation - Business Description 28
Business Description - Blood Transfusion Products 28
Blood Transfusion Products - Overview 28
Blood Transfusion Products - Financials 28
Blood Transfusion Products - Technology 28
Business Description - Cardiac and Vascular Products 28
Cardiac and Vascular Products - Overview 28
Cardiac and Vascular Products - Financials 29
Cardiac and Vascular Products - Market View 29
Cardiac and Vascular Products - Technology 29
Business Description - General Hospital Products 29
General Hospital Products - Overview 29
General Hospital Products - Financials 29
General Hospital Products - Market View 29
General Hospital Products - Technology 29
Terumo Corporation - SWOT Analysis 30
SWOT Analysis - Overview 30
Terumo Corporation - Strengths 30
Strength - Focused Research and Development Activities 30
Strength - Diversified Product Portfolio 30
Strength - Vast Geographical Presence 30
Terumo Corporation - Weaknesses 31
Weakness - Operational Inefficiency 31
Terumo Corporation - Opportunities 31
Opportunity - Growing Cardiovascular Devices Market 31
Opportunity - Expansion in Emerging Markets 31
Opportunity - Contracts and Agreements 31
Terumo Corporation - Threats 32
Threat - Rise in Raw Material Prices 32
Threat - Intense Competition 32
Threat - Rapid Technological Changes 32
Terumo Corporation - Key Competitors 33
Section 3 - Company Financial Ratios 34
Financial Ratios - Capital Market Ratios 34
Financial Ratios - Annual Ratios 35
Performance Chart 37
Financial Performance 37
Financial Ratios - Interim Ratios 38
Financial Ratios - Ratio Charts 39
Section 4 - Company's Lifesciences Financial Deals and Alliances 40
Terumo Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 40
Terumo Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014 41
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 42
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 43
Terumo Corporation, Recent Deals Summary 44
Section 5 - Company's Recent Developments 45
May 20, 2014: Terumo BCT Enters Agreement with Kaneka Corporation 45
May 15, 2014: TERUMO Launches Expanded GLIDEWAY Access Sheath Portfolio With A New Product For Minimally Invasive Urologic Procedures 45
Mar 27, 2014: Terumo Announces Election of New Board Members 46
Mar 25, 2014: Terumo BCT Becomes Therakos Distributor in Latin America 46
Feb 20, 2014: Terumo Europe announces international showcase for pioneering Iberis system 47
Feb 03, 2014: Terumo Receives CE Mark for Its New Drug-eluting Stent, Ultimaster 47
Dec 16, 2013: U.S. Food and Drug Administration Clears Sickle Cell Disease Indication with New Red Blood Cell Exchange Protocol on the Spectra Optia Apheresis System in the United States 48
Nov 14, 2013: Endovascular Aneurysm Training Module Now Supports Vascutek's Anaconda Devices 48
Nov 13, 2013: Terumo BCT Releases Software 2.0 for Quantum Cell Expansion System 49
Oct 29, 2013: Terumo Interventional Systems Expands Specialty Line of Glidewire Advantage Peripheral Guidewires For Smaller Vessels 50
Section 6 - Appendix 51
Methodology 51
Ratio Definitions 51
About GlobalData 55
Contact Us 55
Disclaimer 55

List of Tables

Terumo Corporation, Key Facts 6
Terumo Corporation, Key Employees 7
Terumo Corporation, Key Employee Biographies 10
Terumo Corporation, Key Operational Employees 11
Terumo Corporation, Major Products and Services 12
Terumo Corporation Number of Pipeline Products by Equipment Type 14
Terumo Corporation Pipeline Products by Equipment Type 15
Terumo Corporation Number of Pipeline Products by Development Stage 16
Terumo Corporation Pipeline Products by Development Stage 17
Terumo Corporation, History 18
Terumo Corporation, Other Locations 25
Terumo Corporation, Subsidiaries 26
Terumo Corporation, Key Competitors 33
Terumo Corporation, Ratios based on current share price 34
Terumo Corporation, Annual Ratios 35
Terumo Corporation, Interim Ratios 38
Terumo Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 40
Terumo Corporation, Medical Equipment, Deals By Type, 2008 to YTD 2014 41
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 42
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Type, 2008 to YTD 2014 43
Terumo Corporation, Recent Deals Summary 44
Currency Codes 51
Capital Market Ratios 51
Equity Ratios 52
Profitability Ratios 52
Cost Ratios 53
Liquidity Ratios 53
Leverage Ratios 54
Efficiency Ratios 54

List of Figures

Terumo Corporation Pipeline Products by Equipment Type 14
Terumo Corporation Pipeline Products by Development Stage 16
Terumo Corporation, Performance Chart (2010 - 2014) 37
Terumo Corporation, Ratio Charts 39
Terumo Corporation, Medical Equipment, Deals By Year, 2008 to YTD 2014 40
Terumo Corporation, Medical Equipment, Deals by Type, 2008 to YTD 2014 41
Terumo Corporation, Pharmaceuticals and Healthcare, Deals By Year, 2008 to YTD 2014 42
Terumo Corporation, Pharmaceuticals and Healthcare, Deals by Type, 2008 to YTD 2014 43

View This Report »

Find all the market research you need - instantly, in one place.

+1.2 Million Research Documents & Statistics +200,000 Trusted Public Sources 350 Industries With Global Coverage

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.